Leaderboard
Insiders and issuers ranked by realized signed return on open-market Form 4 trades. Returns are signed: a sale followed by a rally counts against the seller.
What the metrics mean
Return - the insider's signed return per trade, averaged. A +10% stock move on a buy scores +10%; on a sell, -10%. Because most insider activity is concentrated at rallying stocks, this metric correlates with raw stock performance and doesn't fully isolate timing skill from market drift.
Edge - signed return minus the stock's average forward N-day return over the same period. An insider with +5% edge consistently chose better days to trade than someone who'd picked a random day in the same window. Isolates timing skill from "the stock just went up."
Neither metric is the same as ranking stocks by raw return - that would just surface the best-performing tickers, which you can get from any market screener.
Insiders ranked
749
Showing 50 of 749
Quality filters
10+ trades
≥3 issuers, 50% price coverage
Window
5y trailing
Trade date filter
| # | Insider | Trades | Issuers | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|---|---|
| 51 | Alphabet Inc. | 208/211 | 6 | 86% | +15.4% | +19.8% | +59.8% | -24.1% |
| 52 | Fmr LLC | 14/27 | 5 | 71% | +15.3% | +30.5% | +31.2% | -15.4% |
| 53 | Schwab Andrew J. | 32/44 | 9 | 72% | +14.7% | +17.3% | +42.3% | -26.1% |
| 54 | Radoff Family Foundation | 11/21 | 4 | 82% | +14.6% | +4.9% | +48.6% | -2.0% |
| 55 | Rodgers Thurman J | 32/38 | 4 | 97% | +14.5% | +13.6% | +55.6% | -15.9% |
| 56 | Cornog William L | 11/12 | 3 | 73% | +14.4% | +9.2% | +50.0% | -7.9% |
| 57 | Strobeck Matthew | 17/24 | 4 | 71% | +13.7% | +5.0% | +36.4% | -25.1% |
| 58 | Atchinson Robert | 23 | 3 | 96% | +13.7% | +12.6% | +21.4% | -11.3% |
| 59 | Gross Phillip | 23 | 3 | 96% | +13.7% | +12.6% | +21.4% | -11.3% |
| 60 | Mudrick Capital Management, L.P. | 65 | 3 | 94% | +13.6% | +9.3% | +40.5% | -7.3% |
| 61 | Mudrick Jason | 65 | 3 | 94% | +13.6% | +9.3% | +40.5% | -7.3% |
| 62 | Martin William C | 24 | 3 | 71% | +13.4% | +12.6% | +54.1% | -10.5% |
| 63 | Orbimed Capital Gp VI LLC | 84/109 | 13 | 63% | +13.2% | +17.4% | +53.5% | -31.1% |
| 64 | Brookfield Corp /On/ | 126/133 | 7 | 75% | +13.1% | +7.4% | +35.3% | -11.2% |
| 65 | McGuire Terrance | 19 | 4 | 84% | +12.9% | +13.6% | +34.5% | -22.2% |
| 66 | Ra Capital Nexus Fund, L.P. | 85/90 | 10 | 40% | +12.7% | -7.9% | +104.3% | -38.0% |
| 67 | Leuschen David M | 58/64 | 3 | 71% | +12.5% | +5.1% | +41.8% | -41.1% |
| 68 | Orbimed Genesis Gp LLC | 91/171 | 18 | 62% | +12.5% | +15.9% | +136.4% | -34.1% |
| 69 | Orbimed Capital Gp VIII LLC | 62/83 | 6 | 76% | +12.5% | +13.0% | +45.5% | -23.1% |
| 70 | Baker Bros. Advisors LP | 390/430 | 15 | 85% | +12.3% | +12.3% | +94.7% | -85.2% |
| 71 | Baker Felix | 390/430 | 15 | 85% | +12.3% | +12.3% | +94.7% | -85.2% |
| 72 | Baker Julian | 390/430 | 15 | 85% | +12.3% | +12.3% | +94.7% | -85.2% |
| 73 | Baker Bros. Advisors (Gp) LLC | 390/430 | 15 | 85% | +12.3% | +12.3% | +94.7% | -85.2% |
| 74 | Tc Group, LLC | 72/87 | 5 | 89% | +11.4% | +12.9% | +52.8% | -11.8% |
| 75 | Daly James M | 22 | 3 | 95% | +11.4% | +13.0% | +17.7% | -20.8% |
| 76 | Corre Partners Management, LLC | 80/92 | 3 | 45% | +11.4% | -1.1% | +106.1% | -23.0% |
| 77 | Biotechnology Value Fund II LP | 71/111 | 11 | 66% | +11.3% | +11.9% | +76.1% | -29.1% |
| 78 | Biotechnology Value Fund L P | 71/111 | 11 | 66% | +11.3% | +11.9% | +76.1% | -29.1% |
| 79 | Bvf Gp Holdings LLC | 71/111 | 11 | 66% | +11.3% | +11.9% | +76.1% | -29.1% |
| 80 | Bvf I Gp LLC | 71/111 | 11 | 66% | +11.3% | +11.9% | +76.1% | -29.1% |
| 81 | Bvf II Gp LLC | 71/111 | 11 | 66% | +11.3% | +11.9% | +76.1% | -29.1% |
| 82 | Bvf Inc/Il | 71/111 | 11 | 66% | +11.3% | +11.9% | +76.1% | -29.1% |
| 83 | Bvf Partners L P/Il | 71/111 | 11 | 66% | +11.3% | +11.9% | +76.1% | -29.1% |
| 84 | Bvf Partners Os Ltd. | 71/111 | 11 | 66% | +11.3% | +11.9% | +76.1% | -29.1% |
| 85 | Biotechnology Value Trading Fund Os LP | 71/111 | 11 | 66% | +11.3% | +11.9% | +76.1% | -29.1% |
| 86 | Lampert Mark N | 71/111 | 11 | 66% | +11.3% | +11.9% | +76.1% | -29.1% |
| 87 | Fust Matthew K | 10 | 3 | 100% | +11.2% | +5.5% | +42.0% | +1.2% |
| 88 | Fairmount Healthcare Fund II L.P. | 12/13 | 4 | 75% | +11.0% | +6.5% | +55.7% | -14.5% |
| 89 | Carlyle Holdings I Gp Inc. | 75/90 | 6 | 89% | +11.0% | +12.5% | +52.8% | -11.8% |
| 90 | Carlyle Holdings I Gp Sub L.L.C. | 75/90 | 6 | 89% | +11.0% | +12.5% | +52.8% | -11.8% |
| 91 | Carlyle Holdings I L.P. | 75/90 | 6 | 89% | +11.0% | +12.5% | +52.8% | -11.8% |
| 92 | Fairmount Funds Management LLC | 17/23 | 6 | 82% | +10.9% | +6.2% | +55.7% | -14.5% |
| 93 | Tc Group Sub L.P. | 70/85 | 4 | 89% | +10.9% | +12.9% | +27.8% | -11.8% |
| 94 | Szot Matthew K | 14/15 | 3 | 71% | +10.7% | +6.8% | +43.8% | -10.9% |
| 95 | Leonard Braden Michael | 58/103 | 11 | 74% | +10.7% | +11.3% | +42.7% | -11.9% |
| 96 | Chu Chinh | 31/36 | 3 | 94% | +10.5% | +8.1% | +27.9% | -8.9% |
| 97 | Koh Bong Y | 42/58 | 3 | 74% | +10.5% | +10.4% | +35.5% | -14.5% |
| 98 | Vhcp Co-Investment Holdings III, LLC | 42/58 | 3 | 74% | +10.5% | +10.4% | +35.5% | -14.5% |
| 99 | Vhcp Management Eg, LLC | 42/58 | 3 | 74% | +10.5% | +10.4% | +35.5% | -14.5% |
| 100 | Vhcp Management III, LLC | 42/58 | 3 | 74% | +10.5% | +10.4% | +35.5% | -14.5% |